Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | IP6K1 | Q92551 | 13/20 | 0.57 |
| ▸ | IP6K2 | Q9UHH9 | 10/20 | 0.57 |
| ▸ | IP6K3 | Q96PC2 | 9/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6691319 | 0.93 | ALDH1A1 (0.55) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL31001160 | 0.86 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL23458464 | 0.86 | IP6K1 (0.51) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL1837436 | 0.84 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL8655645 | 0.84 | MEN1 (0.56) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL10397089 | 0.84 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL28602742 | 0.84 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL10396726 | 0.80 | IP6K1 (0.62) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL29080634 | 0.80 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 | |
| SCHEMBL10396913 | 0.80 | IP6K1 (0.47) | ALDH1A1SMN1; SMN2HPGDIP6K1IP6K2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0892846-B1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AG (DE) | 2002-10-23 | — | — | EP | claimed |
| US-6130198-A | Bleaching efficiency boosters for bleach and textile detergent compositions | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-10 | — | — | US | claimed |
| EP-0570714-B1 | Use of aminoalcohol-N-acylderivatives for the manufacture of a medicament for the treatment of neurogenic endoneural oedema of the peripheral nerve | LIFEGROUP SPA (IT) | 1999-09-01 | — | — | EP | claimed |
| EP-0892846-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-27 | — | — | EP | claimed |
| WO-1997035950-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | claimed |
| CN-115475541-A | Poly (quinoline) film | 恩特格里斯公司 | 2022-12-16 | — | — | CN | disclosed |
| US-9868722-B2 | Monocyclic pyrimidine/pyridine compounds as inhibitors of P97 complex | CLEAVE BIOSCIENCES, INC. (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160304495-A1 | MONOCYCLIC PYRIMIDINE/PYRIDINE COMPOUNDS AS INHIBITORS OF P97 COMPLEX | CLEAVE BIOSCIENCES, INC. (US) | 2016-10-20 | — | — | US | disclosed |
| EP-3016984-A2 | USE OF A GEL-LIKE POLYMER COMPOSITION WHICH CAN BE OBTAINED BY POLYMERIZING AN ACID GROUP-CONTAINING MONOMER IN THE PRESENCE OF A POLYETHER COMPOUND IN FORMULATIONS FOR AUTOMATIC DISHWASHING | BASF SE (DE) | 2016-05-11 | — | — | EP | disclosed |
| US-9273012-B2 | Facile preparation of 4-substituted quinazolines and related heterocycles | UNIVERSITY OF HOUSTON SYSTEM (US) | 2016-03-01 | — | — | US | disclosed |
| WO-2015000969-A2 | USE OF A GEL-LIKE POLYMER COMPOSITION WHICH CAN BE OBTAINED BY POLYMERIZING AN ACID GROUP-CONTAINING MONOMER IN THE PRESENCE OF A POLYETHER COMPOUND IN FORMULATIONS FOR AUTOMATIC DISHWASHING | BASF SE (DE) | 2015-01-08 | — | — | WO | disclosed |
| WO-2012151141-A2 | A FACILE PREPARATION OF 4-SUBSTITUTED QUINAZOLINES AND RELATED HETEROCYCLES | UNIVERSITY OF HOUSTON SYSTEM (US) | 2012-11-08 | — | — | WO | disclosed |
| WO-2002014266-A1 | METHOD FOR PRODUCING ALKYL ARYL SULPHONATES | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-21 | — | — | WO | disclosed |
| US-20010031869-A1 | Processes and synthetic intermediates for preparing N-arylacridancarboxylic acid derivatives | LUMIGEN, INC. | 2001-10-18 | — | — | US | disclosed |
| US-6130198-A | Bleaching efficiency boosters for bleach and textile detergent compositions | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-10 | — | — | US | disclosed |
| EP-0958345-A2 | ACTIVATORS FOR PER COMPOUNDS | ORACLE CORPORATION (US) | 1999-11-24 | — | — | EP | disclosed |
| EP-0892846-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-27 | — | — | EP | disclosed |
| WO-1998033878-A2 | ACTIVATORS FOR PER COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-08-06 | — | — | WO | disclosed |
| WO-1997035950-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | disclosed |
| US-3931172-A | 1-Tertiary-butyl-3-morpholino-3-phenyl-2,1-benzisoxaxolines | SANDOZ INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304495-A1 | MONOCYCLIC PYRIMIDINE/PYRIDINE COMPOUNDS AS INHIBITORS OF P97 COMPLEX | PSMG3, PSMD2, PSME1 | ALDH1A1 2684/4885SMN1; SMN2 2135/4885HPGD 2966/4885 |
| US-20010031869-A1 | Processes and synthetic intermediates for preparing N-arylacridancarboxylic acid derivatives | ALDH3A1, AADAC, SPR | ALDH1A1 64/4885SMN1; SMN2 4285/4885HPGD 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.